| Product No. | Product Name | Size |
| Prices effective: 01-Feb-06 | | |
| ALX-210-756-C100 | PAb to MMP-9 | 100.micro.g |
| ALX-210-762-C200 | PAb to CCR8 (human) | 200.micro.g |
| ALX-210-763-C500 | PAb to Topoisomerase IIalpha (human) | 500.micro.g |
| ALX-210-764-C100 | PAb to CCR8 (human) | 100.micro.g |
| ALX-210-765-1 | PAb to PAF Acetylhydrolase (human) | 1 Vial |
| ALX-210-766-1 | PAb to Phospholipase A2 (Calcium-independent) (Cytosolic) | 1 Vial |
| ALX-210-767-R100 | PAb to (E)-4-Hydroxynonenal | 100.micro.l |
| ALX-210-768-C200 | PAb to p51A | 200.micro.g |
| ALX-210-769-C200 | PAb to p51B | 200.micro.g |
| ALX-210-770-C200 | PAb to pp36 (human) | 200.micro.g |
| ALX-210-771-1 | PAb to PARP-1 (1-232) (human) | 1 Vial |
| ALX-210-772-1 | PAb to PARP-1 (337-573) (human) | 1 Vial |
| ALX-210-781-R100 | PAb to RasGAP (CT) | 100.micro.l |
| ALX-210-785-C100 | PAb to Voltage-dependent Anion Channel (rat) | 100.micro.g |
| ALX-210-788-C100 | PAb to Smac / DIABLO (human) | 100.micro.g |
| ALX-210-789-C100 | PAb to Cyclophilin D | 100.micro.g |
| ALX-210-790-C100 | PAb to SCAMP1 (rat) | 100.micro.g |
| ALX-210-791-C100 | PAb to VAMP-1 | 100.micro.g |
| ALX-210-792-C100 | PAb to VAMP-2 | 100.micro.g |
| ALX-210-793-C100 | PAb to Rab 3A | 100.micro.g |
| ALX-210-794-C100 | PAb to Rab 3C (mouse) | 100.micro.g |
| ALX-210-795-C100 | PAb to Rabphilin 3A (rat) | 100.micro.g |
| ALX-210-796-C100 | PAb to 6X-HIS Epitope Tag | 100.micro.g |
| ALX-210-798-R100 | PAb to ATRIP (human) | 100.micro.l |
| ALX-210-799-C100 | PAb to BAFF (CT) | 100.micro.g |
| ALX-210-800-C100 | PAb to TACI | 100.micro.g |
| ALX-210-801-C100 | PAb to Troy | 100.micro.g |
| ALX-210-802-R100 | PAb to 8-Hydroxyguanosine | 100.micro.l |
| ALX-210-803-C100 | PAb to Ataxia telangiectasia Mutated (human) | 100.micro.g |
| ALX-210-804-C100 | PAb to Caspase-1 | 100.micro.g |
| ALX-210-806-C100 | PAb to Caspase-3 | 100.micro.g |
| ALX-210-807-C100 | PAb to Caspase-3 (active) | 100.micro.g |
| ALX-210-808-C100 | PAb to Caspase-4 | 100.micro.g |
| ALX-210-809-C100 | PAb to Caspase-5 | 100.micro.g |
| ALX-210-810-C100 | PAb to Caspase-6 | 100.micro.g |
| ALX-210-811-C100 | PAb to Caspase-7 | 100.micro.g |
| ALX-210-812-C100 | PAb to Caspase-7 | 100.micro.g |
| ALX-210-813-C100 | PAb to Caspase-7 (active) | 100.micro.g |
| ALX-210-815-C100 | PAb to Caspase-9 | 100.micro.g |
| ALX-210-816-C100 | PAb to Caspase-9 (active) | 100.micro.g |
| ALX-210-818-C100 | PAb to Caspase-11 | 100.micro.g |
| ALX-210-819-C200 | PAb to CXCR4 (mouse) | 200.micro.g |
| ALX-210-820-C200 | PAb to CXCR4 (human) | 200.micro.g |
| ALX-210-821-C200 | PAb to CCR2 (human) | 200.micro.g |
| ALX-210-822-C200 | PAb to CCR3 (human) | 200.micro.g |
| ALX-210-823-C200 | PAb to CCR5 (human) | 200.micro.g |
| ALX-210-825-C100 | PAb to CD137 (mouse) | 100.micro.g |
| ALX-210-826-C100 | PAb to CD27 (mouse) | 100.micro.g |
| ALX-210-827-C100 | PAb to Lck (human) | 100.micro.g |
| ALX-210-828-C100 | PAb to CD3zeta (22-30) | 100.micro.g |
| ALX-210-829-C100 | PAb to CD3zeta (154-164) | 100.micro.g |
| ALX-210-833-R100 | PAb to MMP-13 (human) | 100.micro.l |
| ALX-210-834-R100 | PAb to MMP-14 (human) | 100.micro.l |
| ALX-210-835-R100 | PAb to MMP-15 (human) | 100.micro.l |
| ALX-210-838-R100 | PAb to Caspase-9 (human) | 100.micro.l |
| ALX-210-839-C200 | PAb to beta-Chemokine Receptor D6 (human) | 200.micro.g |
| ALX-210-840-C100 | PAb to CCR10 (human) | 100.micro.g |
| ALX-210-841-C100 | PAb to MRP1 (A23) | 100.micro.g |
| ALX-210-842-C200 | PAb to Caspase-14 (mouse) | 200.micro.g |
| ALX-210-843-C200 | PAb to CCR6 | 200.micro.g |
| ALX-210-844-C100 | PAb to CCR7 | 100.micro.g |
| ALX-210-845-C200 | PAb to CCR8 (mouse) | 200.micro.g |
| ALX-210-846-C200 | PAb to CCR9 | 200.micro.g |
| ALX-210-847-C200 | PAb to CCR9 (human) | 200.micro.g |
| ALX-210-848-C200 | PAb to CCR10 (mouse) | 200.micro.g |
| ALX-210-849-C200 | PAb to CCR10 (human) | 200.micro.g |
| ALX-210-851-C200 | PAb to beta-Chemokine Receptor D6 (mouse) | 200.micro.g |
| ALX-210-852-C200 | PAb to Toll-like Receptor 2 (human) | 200.micro.g |
| ALX-210-853-C200 | PAb to Toll-like Receptor 5 (human) | 200.micro.g |
| ALX-210-854-C100 | PAb to VAMP-3 (rat) | 100.micro.g |
| ALX-210-855-C100 | PAb to Rab 3D (mouse) | 100.micro.g |
| ALX-210-856-R200 | PAb to MRP4 (human) | 200.micro.l |
| ALX-210-857-C100 | PAb to SCAMP2 | 100.micro.g |
| ALX-210-859-C100 | PAb to Bcl-XL | 100.micro.g |
| ALX-210-860-R100 | PAb to RasGAP (NT) | 100.micro.l |
| ALX-210-862-R200 | PAb to SENP1 | 200.micro.l |
| ALX-210-863-R200 | PAb to SENP2 | 200.micro.l |
| ALX-210-864-C100 | PAb to SENP3 | 100.micro.g |
| ALX-210-865-R200 | PAb to SENP5 | 200.micro.l |
| ALX-210-866-C100 | PAb to SENP6 | 100.micro.g |
| ALX-210-867-1 | PAb to Guanylyl Cyclase (beta1), Soluble | 1 Vial |
| ALX-210-868-R200 | PAb to Guanylyl Cyclase alpha1, Soluble (human) | 200.micro.l |
| ALX-210-869-R200 | PAb to NOSIP | 200.micro.l |
| ALX-210-870-R200 | PAb to Guanylyl Cyclase beta1, Soluble (human) | 200.micro.l |
| ALX-210-871-R200 | PAb to NOSTRIN (human) | 200.micro.l |
| ALX-210-872-R200 | PAb to Bradykinin B2 Receptor [B2R] | 200.micro.l |
| ALX-210-873-C100 | PAb to Toll-like Receptor 6 (mouse) | 100.micro.g |
| ALX-210-874-C100 | PAb to Toll-like Receptor 7 | 100.micro.g |
| ALX-210-874PF-C100 | PAb to Toll-like Receptor 7 (preservative free) | 100.micro.g |
| ALX-210-875-R200 | PAb to MD-2 (human) | 200.micro.l |
| ALX-210-876-C100 | PAb to MMP-1 | 100.micro.g |
| ALX-210-877-C100 | PAb to MMP-3 | 100.micro.g |
| ALX-210-878-1 | PAb to Guanylyl Cyclase (alpha Subunit), Soluble | 1 Vial |
| ALX-210-879-R100 | PAb to Malondialdehyde [MDA] | 100.micro.l |
| ALX-210-880-C025 | PAb to VASP (affinity purified) | 25.micro.g |
| ALX-210-881-C100 | PAb to Acrolein | 100.micro.g |
| ALX-210-882-R100 | PAb to Formaldehyde | 100.micro.l |
| ALX-210-883-C100 | PAb to CHIP (human) | 100.micro.g |
| ALX-210-884-C100 | PAb to alpha-COP | 100.micro.g |
| ALX-210-885-R100 | PAb to c-IAP1 | 100.micro.l |
| ALX-210-886-C100 | PAb to beta'-COP (rat) | 100.micro.g |
| ALX-210-888-C100 | PAb to Caveolin-2 (phosphorylated) (pTyr19) (mouse) | 100.micro.g |
| ALX-210-889-R100 | PAb to PDIA6 (human) | 100.micro.l |
| ALX-210-890-R100 | PAb to Poly(ADP-ribose) (96-10-04) | 100.micro.l |
| ALX-210-891-R100 | PAb to HSP25 (phosphorylated) (pSer86) | 100.micro.l |
| ALX-210-893-R050 | PAb to EGR-4 Protein | 50.micro.l |
| ALX-210-894-C100 | PAb to Tenascin-W | 100.micro.g |
| ALX-210-895-R100 | PAb to PARP-1 (human) | 100.micro.l |
| ALX-210-896-R100 | PAb to PARP-2 | 100.micro.l |
| ALX-210-897-R100 | PAb to PARP-1 (human) | 100.micro.l |
| ALX-210-900-R100 | PAb to MyD88 | 100.micro.l |
| ALX-210-901-R100 | PAb to SPRR2 (human) | 100.micro.l |
| ALX-210-902-R100 | PAb to SPRR3 (human) (4A) | 100.micro.l |
| ALX-210-903-R100 | PAb to CARMA1 (AL220) | 100.micro.l |
| ALX-210-904-R100 | PAb to NALP1 (human) (AL176) | 100.micro.l |
| ALX-210-905-R100 | PAb to Asc (AL177) | 100.micro.l |
| ALX-210-906-R050 | PAb to HtrA2 / Omi | 50.micro.l |
| ALX-210-906-R100 | PAb to HtrA2 / Omi | 100.micro.l |
| ALX-210-907-R100 | PAb to Fis1 | 100.micro.l |
| ALX-210-908-C050 | PAb to TRIF (human) (AL227) | 50.micro.g |
| ALX-210-909-R050 | PAb to XIAP | 50.micro.l |
| ALX-210-909-R100 | PAb to XIAP | 100.micro.l |
| ALX-210-910-C050 | PAb to CYLD (human) (AF888) | 50.micro.g |
| ALX-210-911-C100 | PAb to NM23-H1 (K73) | 100.micro.g |
| ALX-210-912-C100 | PAb to PRUNE (human) (A59) | 100.micro.g |
| ALX-210-913-R100 | PAb to Adiponectin Receptor 1 (human) (AL238) | 100.micro.l |
| ALX-210-914-R050 | PAb to TRAM (human) (AL239) | 50.micro.l |
| ALX-210-915-C050 | PAb to RAIDD (human) (AT100) | 50.micro.g |
| ALX-210-916-R100 | PAb to Adiponectin Receptor 2 (mouse) (AL241) | 100.micro.l |
| ALX-210-917-C050 | PAb to SET (human) | 50.micro.g |
| ALX-210-918-C050 | PAb to Nod1 (human) (AL184) | 50.micro.g |
| ALX-210-919-C050 | PAb to SODD (human) (AL169) | 50.micro.g |
| ALX-210-920-C050 | PAb to PIDD (human) (AL233) | 50.micro.g |
| ALX-210-921-C050 | PAb to Nerve Growth Factor Receptor (human) (AT101) | 50.micro.g |
| ALX-210-922-C050 | PAb to Comulin (human) (SZ1229) | 50.micro.g |
| ALX-210-923-C050 | PAb to CTRP2 (mouse) (AT102) | 50.micro.g |
| ALX-210-924-C050 | PAb to CTRP7 (mouse) (AT103) | 50.micro.g |
| ALX-210-925-C050 | PAb to Repetin (human9 (AF646) | 50.micro.g |
| ALX-210-926-C050 | PAb to TWEAK (human) (AT104) | 50.micro.g |
| ALX-210-927-C050 | PAb to TL1A (human) (AT105 | 50.micro.g |
| ALX-210-928-C100 | PAb to LRRK2 (human) (AT106) | 100.micro.g |
| ALX-211-051-C100 | PAb to Rat IgG (Mouse Ig adsorbed) (FITC) | 100.micro.g |
| ALX-211-052-R050 | PAb to Rat IgG (Mouse Ig adsorbed) (HRP) | 50.micro.l |
| ALX-211-053-C050 | PAb to Rat IgG (Mouse Ig adsorbed) (R-PE) | 50.micro.g |
| ALX-211-054-C100 | PAb to Rat IgM (FITC) | 100.micro.g |
| ALX-211-055-R050 | PAb to Rat IgM (HRP) | 50.micro.l |
| ALX-211-056-C050 | PAb to Rat IgM (R-PE) | 50.micro.g |
| ALX-211-057-C100 | PAb to Rat IgM (Biotin) | 100.micro.g |
| ALX-211-058-C100 | PAb to Rat IgG (Mouse Ig adsorbed) (Biotin) | 100.micro.g |
| ALX-211-059TD-C100 | PAb to Rat IgG (Mouse Ig adsorbed) (ATTO 488) | 100.micro.g |
| ALX-211-059TM-C100 | PAb to Rat IgG (Mouse Ig adsorbed) (ATTO 590) | 100.micro.g |
| ALX-211-200-C100 | PAb to Mouse IgG1 (FITC) | 100.micro.g |
| ALX-211-201-C050 | PAb to Mouse IgG1 (R-PE) | 50.micro.g |
| ALX-211-202-C100 | PAb to Mouse IgG1 (Biotin) | 100.micro.g |
| ALX-211-203-R050 | PAb to Mouse IgG1 (HRP) | 50.micro.l |
| ALX-211-204TD-C100 | PAb to Mouse IgG1 (ATTO 488) | 100.micro.g |
| ALX-211-204TM-C100 | PAb to Mouse IgG1 (ATTO 590) | 100.micro.g |
| ALX-211-205TD-C100 | PAb to Mouse IgG (ATTO 488) | 100.micro.g |
| ALX-211-205TM-C100 | PAb to Mouse IgG (ATTO 490) | 100.micro.g |
| ALX-211-500-C100 | PAb to Human IgG (gamma-chain specific) (FITC) | 100.micro.g |
| ALX-211-501-C050 | PAb to Human IgG (gamma-chain specific) (R-PE) | 50.micro.g |
| ALX-211-502-C100 | PAb to Human IgG (gamma-chain specific) (Biotin) | 100.micro.g |
| ALX-211-650TD-C100 | PAb to Mouse IgG (ATTO 488) | 100.micro.g |
| ALX-211-650TM-C100 | PAb to Mouse IgG (ATTO 590) | 100.micro.g |
| ALX-215-004-C200 | PAb to HSP40 (human) | 200.micro.g |
| ALX-215-005-C200 | PAb to HSP47 (human) | 200.micro.g |
| ALX-260-001-M005 | PPACK . trifluoroacetate | 5 mg |
| ALX-260-003-M001 | Amastatin . hydrochloride | 1 mg |
| ALX-260-003-M005 | Amastatin . hydrochloride | 5 mg |
| ALX-260-005-M001 | Chymostatin | 1 mg |
| ALX-260-005-M005 | Chymostatin | 5 mg |
| ALX-260-006-M001 | Chloroacetyl-HOLeu-Ala-Gly-NH2 | 1 mg |
| ALX-260-006-M005 | Chloroacetyl-HOLeu-Ala-Gly-NH2 | 5 mg |
| ALX-260-007-M005 | E-64 | 5 mg |
| ALX-260-007-M025 | E-64 | 25 mg |
| ALX-260-008-M001 | Foroxymithine | 1 mg |
| ALX-260-009-M005 | Leupeptin (synthetic) | 5 mg |
| ALX-260-009-M025 | Leupeptin (synthetic) | 25 mg |
| ALX-260-009-M100 | Leupeptin (synthetic) | 100 mg |
| ALX-260-011-M001 | Phosphoramidon | 1 mg |
| ALX-260-011-M005 | Phosphoramidon | 5 mg |
| ALX-260-012-M005 | Bestatin . hydrochloride | 5 mg |
| ALX-260-012-M025 | Bestatin . hydrochloride | 25 mg |
| ALX-260-013-M005 | Diprotin B | 5 mg |
| ALX-260-013-M025 | Diprotin B | 25 mg |
| ALX-260-014-M005 | Calpeptin | 5 mg |
| ALX-260-014-M010 | Calpeptin | 10 mg |
| ALX-260-016-M001 | Ac-YVAD-2,6-dimethylbenzoyloxymethylketone | 1 mg |
| ALX-260-016-M005 | Ac-YVAD-2,6-dimethylbenzoyloxymethylketone | 5 mg |
| ALX-260-017-M001 | CA-074 | 1 mg |
| ALX-260-019-M001 | Biotinyl-YVAD-CMK | 1 mg |
| ALX-260-019-M005 | Biotinyl-YVAD-CMK | 5 mg |
| ALX-260-020-M001 | Z-VAD-FMK | 1 mg |
| ALX-260-020-M005 | Z-VAD-FMK | 5 mg |
| ALX-260-021-M001 | H-Cys-4-Abz-Met-OH | 1 mg |
| ALX-260-021-M005 | H-Cys-4-Abz-Met-OH | 5 mg |
| ALX-260-022-M001 | Furin Convertase Inhibitor (Chloromethylketone) | 1 mg |
| ALX-260-022-M005 | Furin Convertase Inhibitor (Chloromethylketone) | 5 mg |
| ALX-260-023-M001 | Mca-YVADAPK(Dnp)-OH | 1 mg |
| ALX-260-024-M001 | Ac-YVAD-AMC | 1 mg |
| ALX-260-024-M005 | Ac-YVAD-AMC | 5 mg |
| ALX-260-026-M001 | Ac-YVAD-pNA | 1 mg |
| ALX-260-026-M005 | Ac-YVAD-pNA | 5 mg |
| ALX-260-027-M001 | Ac-YVAD-CHO | 1 mg |
| ALX-260-027-M005 | Ac-YVAD-CHO | 5 mg |
| ALX-260-028-M001 | Ac-YVAD-CMK | 1 mg |
| ALX-260-028-M005 | Ac-YVAD-CMK | 5 mg |
| ALX-260-029-M010 | Z-Asp-2,6-dichlorobenzoyloxymethylketone | 10 mg |
| ALX-260-029-M050 | Z-Asp-2,6-dichlorobenzoyloxymethylketone | 50 mg |
| ALX-260-030-M001 | Ac-DEVD-CHO | 1 mg |
| ALX-260-030-M005 | Ac-DEVD-CHO | 5 mg |
| ALX-260-031-M001 | Ac-DEVD-AMC | 1 mg |
| ALX-260-031-M005 | Ac-DEVD-AMC | 5 mg |
| ALX-260-032-M001 | Ac-DEVD-AFC | 1 mg |
| ALX-260-032-M005 | Ac-DEVD-AFC | 5 mg |
| ALX-260-033-M001 | Ac-DEVD-pNA | 1 mg |
| ALX-260-033-M005 | Ac-DEVD-pNA | 5 mg |
| ALX-260-034-M001 | Biotinyl-DEVD-CHO | 1 mg |
| ALX-260-034-M005 | Biotinyl-DEVD-CHO | 5 mg |
| ALX-260-035-M001 | Z-YVAD-AFC | 1 mg |
| ALX-260-035-M005 | Z-YVAD-AFC | 5 mg |
| ALX-260-036-M005 | Diprotin A | 5 mg |
| ALX-260-036-M025 | Diprotin A | 25 mg |
| ALX-260-037-M010 | Calpain Inhibitor I | 10 mg |
| ALX-260-037-M050 | Calpain Inhibitor I | 50 mg |
| ALX-260-038-M010 | Calpain Inhibitor II | 10 mg |
| ALX-260-038-M050 | Calpain Inhibitor II | 50 mg |
| ALX-260-039-M001 | Z-VAD(OMe)-FMK | 1 mg |
| ALX-260-039-M005 | Z-VAD(OMe)-FMK | 5 mg |
| ALX-260-040-M001 | Furin Convertase Substrate (Fluorogenic) | 1 mg |
| ALX-260-040-M005 | Furin Convertase Substrate (Fluorogenic) | 5 mg |
| ALX-260-042-M001 | Ac-IETD-AMC | 1 mg |
| ALX-260-042-M005 | Ac-IETD-AMC | 5 mg |
| ALX-260-043-M001 | Ac-IETD-CHO | 1 mg |
| ALX-260-043-M005 | Ac-IETD-CHO | 5 mg |
| ALX-260-044-M001 | Z-IETD-pNA | 1 mg |
| ALX-260-044-M005 | Z-IETD-pNA | 5 mg |
| ALX-260-045-M001 | Ac-IETD-pNA | 1 mg |
| ALX-260-045-M005 | Ac-IETD-pNA | 5 mg |
| ALX-260-046-M001 | Ac-AAVALLPAVLLALLAPDEVD-CHO | 1 mg |
| ALX-260-046-M005 | Ac-AAVALLPAVLLALLAPDEVD-CHO | 5 mg |
| ALX-260-047-M001 | Ac-AAVALLPAVLLALLAPYVAD-CHO | 1 mg |
| ALX-260-047-M005 | Ac-AAVALLPAVLLALLAPYVAD-CHO | 5 mg |
| ALX-260-048-M001 | Z-DEVD-pNA | 1 mg |
| ALX-260-048-M005 | Z-DEVD-pNA | 5 mg |
| ALX-260-049-M001 | Z-YVAD-pNA | 1 mg |
| ALX-260-049-M005 | Z-YVAD-pNA | 5 mg |
| ALX-260-050-M001 | BAADT | 1 mg |
| ALX-260-050-M005 | BAADT | 5 mg |
| ALX-260-054-M005 | Suc-Leu-Tyr-AMC (Fluorogenic) | 5 mg |
| ALX-260-055-M001 | Ac-WEHD-CHO | 1 mg |
| ALX-260-055-M005 | Ac-WEHD-CHO | 5 mg |
| ALX-260-056-M001 | Ac-ESMD-CHO | 1 mg |
| ALX-260-056-M005 | Ac-ESMD-CHO | 5 mg |
| ALX-260-057-M001 | Ac-WEHD-AMC | 1 mg |
| ALX-260-057-M005 | Ac-WEHD-AMC | 5 mg |
| ALX-260-058-M001 | Ac-VDVAD-CHO | 1 mg |
| ALX-260-058-M005 | Ac-VDVAD-CHO | 5 mg |
| ALX-260-059-M001 | Ac-VDVAD-pNA | 1 mg |
| ALX-260-059-M005 | Ac-VDVAD-pNA | 5 mg |
| ALX-260-060-M001 | Ac-VDVAD-AMC | 1 mg |
| ALX-260-060-M005 | Ac-VDVAD-AMC | 5 mg |
| ALX-260-061-M001 | Ac-LEVD-pNA | 1 mg |
| ALX-260-061-M005 | Ac-LEVD-pNA | 5 mg |
| ALX-260-062-M001 | Ac-VEID-CHO | 1 mg |
| ALX-260-062-M005 | Ac-VEID-CHO | 5 mg |
| ALX-260-063-M001 | Ac-VEID-pNA | 1 mg |
| ALX-260-063-M005 | Ac-VEID-pNA | 5 mg |
| ALX-260-064-M001 | Ac-VEID-AMC | 1 mg |
| ALX-260-064-M005 | Ac-VEID-AMC | 5 mg |
| ALX-260-065-M001 | Ac-LEVD-CHO | 1 mg |
| ALX-260-065-M005 | Ac-LEVD-CHO | 5 mg |
| ALX-260-070-M001 | Proteasome Substrate III (Fluorogenic) | 1 mg |
| ALX-260-070-M005 | Proteasome Substrate III (Fluorogenic) | 5 mg |
| ALX-260-071-M001 | Boc-D(OMe)-FMK | 1 mg |
| ALX-260-071-M005 | Boc-D(OMe)-FMK | 5 mg |
| ALX-260-072-M001 | Z-D(OMe)E(OMe)VD(OMe)-FMK | 1 mg |
| ALX-260-072-M005 | Z-D(OMe)E(OMe)VD(OMe)-FMK | 5 mg |
| ALX-260-073-M001 | Z-IE(OMe)TD(OMe)-FMK | 1 mg |
| ALX-260-073-M005 | Z-IE(OMe)TD(OMe)-FMK | 5 mg |
| ALX-260-074-M001 | Z-YVAD(OMe)-FMK | 1 mg |
| ALX-260-075-M001 | Z-VE(OMe)ID(OMe)-FMK | 1 mg |
| ALX-260-076-M001 | Z-LE(OMe)HD(OMe)-FMK | 1 mg |
| ALX-260-076-M005 | Z-LE(OMe)HD(OMe)-FMK | 5 mg |
| ALX-260-077-M001 | Ac-DMQD-CHO | 1 mg |
| ALX-260-077-M005 | Ac-DMQD-CHO | 5 mg |
| ALX-260-078-M001 | Ac-DMQD-AMC | 1 mg |
| ALX-260-078-M005 | Ac-DMQD-AMC | 5 mg |
| ALX-260-079-M001 | Ac-LEHD-CHO | 1 mg |
| ALX-260-079-M005 | Ac-LEHD-CHO | 5 mg |
| ALX-260-080-M001 | Ac-LEHD-AMC | 1 mg |
| ALX-260-080-M005 | Ac-LEHD-AMC | 5 mg |
| ALX-260-081-M001 | Ac-LEHD-pNA | 1 mg |
| ALX-260-081-M005 | Ac-LEHD-pNA | 5 mg |
| ALX-260-082-M001 | Ac-WEHD-pNA | 1 mg |
| ALX-260-082-M005 | Ac-WEHD-pNA | 5 mg |
| ALX-260-083-M001 | Ac-LEVD-AMC | 1 mg |
| ALX-260-083-M005 | Ac-LEVD-AMC | 5 mg |
| ALX-260-084-M001 | Ac-LEVD-AFC | 1 mg |
| ALX-260-084-M005 | Ac-LEVD-AFC | 5 mg |
| ALX-260-085-M005 | Pepstatin A | 5 mg |
| ALX-260-085-M025 | Pepstatin A | 25 mg |
| ALX-260-085-M100 | Pepstatin A | 100 mg |
| ALX-260-086-M001 | Proteasome Substrate II (Fluorogenic) | 1 mg |
| ALX-260-086-M005 | Proteasome Substrate II (Fluorogenic) | 5 mg |
| ALX-260-087-M001 | Proteasome Substrate IV (Fluorogenic) | 1 mg |
| ALX-260-087-M005 | Proteasome Substrate IV (Fluorogenic) | 5 mg |
| ALX-260-088-M001 | Proteasome Substrate I (Fluorogenic) | 1 mg |
| ALX-260-088-M005 | Proteasome Substrate I (Fluorogenic) | 5 mg |
| ALX-260-089-M001 | Proteasome Inhibitor I (Aldehyde) | 1 mg |
| ALX-260-089-M005 | Proteasome Inhibitor I (Aldehyde) | 5 mg |
| ALX-260-090-M001 | Proteasome Inhibitor II (Aldehyde) | 1 mg |
| ALX-260-090-M005 | Proteasome Inhibitor II (Aldehyde) | 5 mg |
| ALX-260-091-M001 | MG-115 | 1 mg |
| ALX-260-091-M005 | MG-115 | 5 mg |
| ALX-260-092-M001 | MG-132 | 1 mg |
| ALX-260-092-M005 | MG-132 | 5 mg |
| ALX-260-093-M005 | Antipain | 5 mg |
| ALX-260-093-M025 | Antipain | 25 mg |
| ALX-260-094-5001 | D2R (high purity) | 5x1 mg |
| ALX-260-094-M001 | D2R (high purity) | 1 mg |
| ALX-260-095-M001 | alpha-MAPI | 1 mg |
| ALX-260-095-M005 | alpha-MAPI | 5 mg |
| ALX-260-098-M001 | Biotinyl-VAD(OMe)-FMK | 1 mg |
| ALX-260-099-M001 | Z-VD(OMe)VAD(OMe)-FMK | 1 mg |
| ALX-260-099-M005 | Z-VD(OMe)VAD(OMe)-FMK | 5 mg |
| ALX-260-102-M001 | Z-LE(OMe)TD(OMe)-FMK | 1 mg |
| ALX-260-103-M001 | Z-D(OMe)QMD(OMe)-FMK | 1 mg |
| ALX-260-104-M001 | Z-LE(OMe)VD(OMe)-FMK | 1 mg |
| ALX-260-104-M005 | Z-LE(OMe)VD(OMe)-FMK | 5 mg |
| ALX-260-108-M005 | Ac-YVAD-AFC | 5 mg |
| ALX-260-108-M010 | Ac-YVAD-AFC | 10 mg |
| ALX-260-109-M005 | Ac-VAD-AFC | 5 mg |
| ALX-260-109-M010 | Ac-VAD-AFC | 10 mg |
| ALX-260-110-M005 | Ac-IETD-AFC | 5 mg |
| ALX-260-110-M010 | Ac-IETD-AFC | 10 mg |
| ALX-260-111-M005 | Ac-VEID-AFC | 5 mg |
| ALX-260-111-M010 | Ac-VEID-AFC | 10 mg |
| ALX-260-112-M005 | Ac-VDVAD-AFC | 5 mg |
| ALX-260-112-M010 | Ac-VDVAD-AFC | 10 mg |
| ALX-260-113-M005 | Ac-DQMD-AFC | 5 mg |
| ALX-260-113-M010 | Ac-DQMD-AFC | 10 mg |
| ALX-260-114-M005 | Ac-AEVD-AFC | 5 mg |
| ALX-260-114-M010 | Ac-AEVD-AFC | 10 mg |
| ALX-260-115-M005 | Ac-IEPD-AFC | 5 mg |
| ALX-260-115-M010 | Ac-IEPD-AFC | 10 mg |
| ALX-260-116-M005 | Ac-LEHD-AFC | 5 mg |
| ALX-260-116-M010 | Ac-LEHD-AFC | 10 mg |
| ALX-260-117-M005 | Ac-WEHD-AFC | 5 mg |
| ALX-260-117-M010 | Ac-WEHD-AFC | 10 mg |
| ALX-260-118-M005 | Ac-LETD-AFC | 5 mg |
| ALX-260-118-M010 | Ac-LETD-AFC | 10 mg |
| ALX-260-120-M005 | Dnp-Pro-Leu-Gly-Met-Trp-Ser-Arg-OH | 5 mg |
| ALX-260-121-M001 | Mca-Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2 | 1 mg |
| ALX-260-122-M001 | Mca-Pro-Cha-Gly-Nva-His-Ala-Dap(Dnp)-NH2 | 1 mg |
| ALX-260-123-M001 | Mca-Pro-Leu-Ala-Nva-Dap(Dnp)-Ala-Arg-NH2 | 1 mg |
| ALX-260-125-M001 | Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 | 1 mg |
| ALX-260-125-M005 | Mca-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 | 5 mg |
| ALX-260-126-M001 | beta-Secretase Inhibitor | 1 mg |
| ALX-260-126-M005 | beta-Secretase Inhibitor | 5 mg |
| ALX-260-127-M001 | gamma-Secretase Inhibitor | 1 mg |
| ALX-260-127-M005 | gamma-Secretase Inhibitor | 5 mg |
| ALX-260-128-M005 | Actinonin | 5 mg |
| ALX-260-129-M005 | Z-Phe-Arg-AFC . trifluoroacetate | 5 mg |
| ALX-260-130-M005 | Z-Phe-Arg-pNA . hydrochloride | 5 mg |
| ALX-260-131-M005 | Z-Phe-Arg-AMC . hydrochloride | 5 mg |
| ALX-260-132-M005 | Z-Phe-Tyr-aldehyde | 5 mg |
| ALX-260-133-M001 | N-(1-Naphthalenylsulfonyl)-Ile-Trp-aldehyde | 1 mg |
| ALX-260-133-M005 | N-(1-Naphthalenylsulfonyl)-Ile-Trp-aldehyde | 5 mg |
| ALX-260-134-M001 | Z-Phe-Tyr(tBu)-diazomethylketone | 1 mg |
| ALX-260-134-M005 | Z-Phe-Tyr(tBu)-diazomethylketone | 5 mg |
| ALX-260-136-M001 | H-Arg-Lys-Leu-Leu-Trp-NH2 | 1 mg |
| ALX-260-136-M005 | H-Arg-Lys-Leu-Leu-Trp-NH2 | 5 mg |
| ALX-260-137-M001 | Histone Deacetylase Substrate (Fluorometric) | 1 mg |
| ALX-260-137-M005 | Histone Deacetylase Substrate (Fluorometric) | 5 mg |
| ALX-260-138-R020 | Z-VAD-FMK (Ready-to-Use) | 20.micro.l |
| ALX-260-138-R100 | Z-VAD-FMK (Ready-to-Use) | 100.micro.l |
| ALX-260-139-R020 | Z-VDVAD-FMK (Ready-to-Use) | 20.micro.l |
| ALX-260-139-R100 | Z-VDVAD-FMK (Ready-to-Use) | 100.micro.l |
| ALX-260-140-R020 | Z-WEHD-FMK (Ready-to-Use) | 20.micro.l |
| ALX-260-140-R100 | Z-WEHD-FMK (Ready-to-Use) | 100.micro.l |
| ALX-260-141-R020 | Z-DEVD-FMK (Ready-to-Use) | 20.micro.l |
| ALX-260-141-R100 | Z-DEVD-FMK (Ready-to-Use) | 100.micro.l |
| ALX-260-142-R020 | Z-LEVD-FMK (Ready-to-Use) | 20.micro.l |
| ALX-260-142-R100 | Z-LEVD-FMK (Ready-to-Use) | 100.micro.l |
| ALX-260-143-R020 | Z-VEID-FMK (Ready-to-Use) | 20.micro.l |
| ALX-260-143-R100 | Z-VEID-FMK (Ready-to-Use) | 100.micro.l |
| ALX-260-144-R020 | Z-IETD-FMK (Ready-to-Use) | 20.micro.l |
| ALX-260-144-R100 | Z-IETD-FMK (Ready-to-Use) | 100.micro.l |
| ALX-260-145-R020 | Z-LEHD-FMK (Ready-to-Use) | 20.micro.l |
| ALX-260-145-R100 | Z-LEHD-FMK (Ready-to-Use) | 100.micro.l |
| ALX-260-146-R020 | Z-AEVD-FMK (Ready-to-Use) | 20.micro.l |
| ALX-260-146-R100 | Z-AEVD-FMK (Ready-to-Use) | 100.micro.l |
| ALX-260-148-R020 | Z-FA-FMK (Ready-to-Use) | 20.micro.l |
| ALX-260-148-R100 | Z-FA-FMK (Ready-to-Use) | 100.micro.l |
| ALX-260-149-C200 | Proteasome Inhibitor lll | 200.micro.g |
| ALX-260-151-M001 | Ac-IEPD-AMC | 1 mg |
| ALX-260-151-M005 | Ac-IEPD-AMC | 5 mg |
| ALX-260-152-M001 | Ac-IEPD-pNA | 1 mg |
| ALX-260-152-M005 | Ac-IEPD-pNA | 5 mg |
| ALX-260-153-R020 | Z-AAD-CMK (Ready-to-Use) | 20.micro.l |
| ALX-260-154-R020 | Z-YVAD-FMK (Ready-to-Use) | 20.micro.l |
| ALX-260-154-R100 | Z-YVAD-FMK (Ready-to-Use) | 100.micro.l |
| ALX-260-157-MC25 | Dnp-Pro-Gln-Gly-Ila-Ala-Gly-Gln-D-Arg-OH | 2.5 mg |
| ALX-260-158-M001 | Ac-AEVD-CHO | 1 mg |
| ALX-260-158-M005 | Ac-AEVD-CHO | 5 mg |
| ALX-260-159-M003 | Q-VD-OPH | 3 mg |
| ALX-260-160-M001 | Ac-LDESD-CHO | 1 mg |
| ALX-260-160-M005 | Ac-LDESD-CHO | 5 mg |
| ALX-260-161-M001 | Ac-TQTD-AFC | 1 mg |
| ALX-260-161-M005 | Ac-TQTD-AFC | 5 mg |
| ALX-270-002-M025 | L-NIO . dihydrochloride | 25 mg |
| ALX-270-002-M100 | L-NIO . dihydrochloride | 100 mg |
| ALX-270-003-M025 | Diphenyleneiodonium chloride | 25 mg |
| ALX-270-003-M100 | Diphenyleneiodonium chloride | 100 mg |
| ALX-270-004-M025 | 7-Nitroindazole | 25 mg |
| ALX-270-004-M100 | 7-Nitroindazole | 100 mg |
| ALX-270-005-G001 | 2,4-Diamino-6-hydroxypyrimidine | 1 g |
| ALX-270-005-M250 | 2,4-Diamino-6-hydroxypyrimidine | 250 mg |
| ALX-270-007-M005 | (2S)-(+)-Amino-5-iodoacetamidopentanoic acid | 5 mg |
| ALX-270-007-M025 | (2S)-(+)-Amino-5-iodoacetamidopentanoic acid | 25 mg |
| ALX-270-008-M005 | (2S)-(+)-Amino-6-iodoacetamidohexanoic acid | 5 mg |
| ALX-270-008-M025 | (2S)-(+)-Amino-6-iodoacetamidohexanoic acid | 25 mg |
| ALX-270-009-M005 | 3-Bromo-7-nitroindazole | 5 mg |
| ALX-270-009-M025 | 3-Bromo-7-nitroindazole | 25 mg |
| ALX-270-009-M050 | 3-Bromo-7-nitroindazole | 50 mg |
| ALX-270-010-M010 | L-NIL . dihydrochloride | 10 mg |
| ALX-270-010-M050 | L-NIL . dihydrochloride | 50 mg |
| ALX-270-011-M005 | Arphamenine A | 5 mg |
| ALX-270-012-M001 | Arphamenine B | 1 mg |
| ALX-270-012-M005 | Arphamenine B | 5 mg |
| ALX-270-013-M001 | Ebelactone A | 1 mg |
| ALX-270-013-M005 | Ebelactone A | 5 mg |
| ALX-270-014-M001 | Ebelactone B | 1 mg |
| ALX-270-014-M005 | Ebelactone B | 5 mg |
| ALX-270-015-M001 | Leuhistin | 1 mg |
| ALX-270-015-M005 | Leuhistin | 5 mg |
| ALX-270-016-M010 | H-7 . dihydrochloride | 10 mg |
| ALX-270-016-M025 | H-7 . dihydrochloride | 25 mg |
| ALX-270-017-M001 | H-89 . dihydrochloride | 1 mg |
| ALX-270-017-M005 | H-89 . dihydrochloride | 5 mg |
| ALX-270-018-M001 | Tyrphostin AG 1288 | 1 mg |
| ALX-270-018-M005 | Tyrphostin AG 1288 | 5 mg |
| ALX-270-018-M025 | Tyrphostin AG 1288 | 25 mg |
| ALX-270-019-M001 | Bisindolylmaleimide I . hydrochloride | 1 mg |
| ALX-270-019-M005 | Bisindolylmaleimide I . hydrochloride | 5 mg |
| ALX-270-020-M001 | Bisindolylmaleimide IX . methanesulfonate | 1 mg |
| ALX-270-020-M005 | Bisindolylmaleimide IX . methanesulfonate | 5 mg |
| ALX-270-021-MC05 | Gö 6976 | 0.5 mg |
| ALX-270-022-G001 | AEBSF . hydrochloride | 1 g |
| ALX-270-022-M050 | AEBSF . hydrochloride | 50 mg |
| ALX-270-022-M250 | AEBSF . hydrochloride | 250 mg |
| ALX-270-023-M010 | alpha-Guanidinoglutaric acid | 10 mg |
| ALX-270-023-M050 | alpha-Guanidinoglutaric acid | 50 mg |
| ALX-270-024-M010 | 1,4-PB-ITU . dihydrobromide | 10 mg |
| ALX-270-024-M050 | 1,4-PB-ITU . dihydrobromide | 50 mg |
| ALX-270-025-M050 | S-Ethyl-ITU . hydrobromide | 50 mg |
| ALX-270-025-M250 | S-Ethyl-ITU . hydrobromide | 250 mg |
| ALX-270-026-M010 | 1,3-PB-ITU . dihydrobromide | 10 mg |
| ALX-270-026-M050 | 1,3-PB-ITU . dihydrobromide | 50 mg |
| ALX-270-027-M050 | S-Methyl-ITU . sulfate | 50 mg |
| ALX-270-027-M250 | S-Methyl-ITU . sulfate | 250 mg |
| ALX-270-028-M010 | S-Isopropyl-ITU . hydrobromide | 10 mg |
| ALX-270-028-M050 | S-Isopropyl-ITU . hydrobromide | 50 mg |
| ALX-270-029-M010 | S-(3-Aminopropyl)-ITU . dihydrobromide | 10 mg |
| ALX-270-029-M050 | S-(3-Aminopropyl)-ITU . dihydrobromide | 50 mg |
| ALX-270-030-M010 | S-(2-Aminoethyl)-ITU . dihydrobromide | 10 mg |
| ALX-270-030-M050 | S-(2-Aminoethyl)-ITU . dihydrobromide | 50 mg |
| ALX-270-031-M001 | Tyrphostin AG 126 | 1 mg |
| ALX-270-031-M005 | Tyrphostin AG 126 | 5 mg |
| ALX-270-033-M010 | AMT . hydrochloride | 10 mg |
| ALX-270-033-M050 | AMT . hydrochloride | 50 mg |
| ALX-270-034-M010 | ODQ | 10 mg |
| ALX-270-034-M050 | ODQ | 50 mg |
| ALX-270-035-M001 | Tyrphostin AG 1295 | 1 mg |
| ALX-270-035-M005 | Tyrphostin AG 1295 | 5 mg |
| ALX-270-036-M001 | Tyrphostin AG 1478 | 1 mg |
| ALX-270-036-M005 | Tyrphostin AG 1478 | 5 mg |
| ALX-270-037-M001 | Tyrphostin AG 1296 | 1 mg |
| ALX-270-037-M005 | Tyrphostin AG 1296 | 5 mg |
| ALX-270-038-M001 | LY-294,002 | 1 mg |
| ALX-270-038-M005 | LY-294,002 | 5 mg |
| ALX-270-038-M025 | LY-294,002 | 25 mg |
| ALX-270-039-M010 | A-3 . hydrochloride | 10 mg |
| ALX-270-039-M050 | A-3 . hydrochloride | 50 mg |
| ALX-270-040-M010 | H-7, Iso-, . dihydrochloride | 10 mg |
| ALX-270-040-M025 | H-7, Iso-, . dihydrochloride | 25 mg |
| ALX-270-044-G001 | 3-Aminobenzamide | 1 g |
| ALX-270-044-G005 | 3-Aminobenzamide | 5 g |
| ALX-270-047-M025 | Aristolochic acid | 25 mg |
| ALX-270-047-M100 | Aristolochic acid | 100 mg |
| ALX-270-049-M001 | Bisindolylmaleimide I | 1 mg |
| ALX-270-049-M005 | Bisindolylmaleimide I | 5 mg |
| ALX-270-050-M001 | Bisindolylmaleimide II | 1 mg |
| ALX-270-050-M005 | Bisindolylmaleimide II | 5 mg |
| ALX-270-051-M001 | Bisindolylmaleimide III | 1 mg |
| ALX-270-051-M005 | Bisindolylmaleimide III | 5 mg |
| ALX-270-052-M001 | Bisindolylmaleimide IV | 1 mg |
